Although the pre-cancerous lesions differ in their occurrence of mutations, most common mutations in pancreatic cancer are activating mutations in KRAS, TP53-deficiency and mutations in SMAD4 [85]. Here, KRAS is linked to familial pancreatic carcinoma.